IL10 and breast carcinoma: In breast cancer TME, TAMs predominantly assume the M2 phenotype, contributing to cancer cell survival and dissemination through the secretion of cytokines (namely, interleukin (IL)-10, transforming growth factor (TGF)-β, and CCL18.